Purchase Order 75N92019P00092

Award Date 4/4/19
Potential Completion Date 12/12/19
Potential Value $37K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10065, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $51,129,580.75 definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract is for early-stage therapeutic development with a Phase II emphasis, and does not have a set-aside designation. Sloan-Kettering Institute has a history of serving as both a prime awardee and subcontractor on federal grants and contracts related to cancer research and patient care, including...
The National Cancer Institute (NCI) awarded a $166,410.58 firm fixed-price purchase order to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The purpose is to procure 620 samples for NCI's Multi-Ancestry Genome-Wide Association Study, with a period of performance from September 25, 2022 through September 24, 2023, and an ultimate completion date of September 25, 2025. This contract has no set-aside designation. Sloan-Kettering Institute for Cancer Research is a...
This is a $123,015,908.00 cost-reimbursement contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract is for the Cancer Information Service, with an ultimate completion date of March 14, 2010. There is no set-aside designation for this contract. The Sloan-Kettering Institute for Cancer Research has previously served as a...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract is part of the NCI Cancer Genome Atlas Program and is valued at $174,500.00. It involves the collection of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract has no set-aside...
This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization focused on cancer research and patient care. The $91,870.79 firm fixed-price delivery order was made under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle and supported the recovery of tissue samples and data from various types of cancer for the Cancer Genome...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization focused on cancer research and patient care. The $178,230.00 award is part of the NCI Cancer Genome Atlas Program and supports the recovery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is funded through the American Recovery and Reinvestment Act (ARRA). The contract has...
This federal contract award, valued at $120,705.00, was issued by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract is associated with the NCI Cancer Genome Atlas Program Tissue Purchase master contract, a Delivery Order contract with a Firm Fixed Price pricing type. The award supports the acquisition of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is a key...
This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization focused on cancer research and patient care. The $211,000.00 firm fixed-price contract is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract is for the provision of tissue samples and data from various types of cancer for...
This is a federal contract award from the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $488,000.00, is for the provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization, under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The $120,500 award provides for the collection and supply of tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program, which is focused on comprehensive genomic characterization of cancers. This award is...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $36,735.52 firm fixed price purchase order to the Sloan-Kettering Institute for Cancer Research, a non-profit organization focused on cancer research and patient care located in New York, NY. The contract is for a scientific investigator with a Ph.D. in biosciences to conclude a study on FAS modulation, cell fate, and its relation to human disease for the NIAMS Autoimmunity Branch. This contract award was not set aside for any specific socioeconomic categories. The contract has a completion date of December 12, 2019. The Sloan-Kettering Institute for Cancer Research is a subsidiary of the Memorial Sloan Kettering Cancer Center, a world-renowned comprehensive cancer center that has expertise in areas such as cancer biology, genomics, immunotherapy, and clinical trials through federal grants and contracts.

Generated 4/9/24, 5:36 PM